SPIRONOLACTONE | A091426 | AMNEAL PHARMACEUTICALS OF NEW YORK LLC
Highest NADAC/Unit
$0.1640
per ea
Lowest NADAC/Unit
$0.0426
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 53746051501SPIRONOLACTONE 100 MG TABLET | $0.1640 | EA | Generic | — | 2026-10-21 |
| 53746051505SPIRONOLACTONE 100 MG TABLET | $0.1640 | EA | Generic | — | 2026-10-21 |
| 53746051401SPIRONOLACTONE 50 MG TABLET | $0.0833 | EA | Generic | — | 2026-10-21 |
| 53746051405SPIRONOLACTONE 50 MG TABLET | $0.0833 | EA | Generic | — | 2026-10-21 |
| 53746051105SPIRONOLACTONE 25 MG TABLET | $0.0426 | EA | Generic | — | 2026-10-21 |
| 53746051110SPIRONOLACTONE 25 MG TABLET | $0.0426 | EA | Generic | — | 2026-10-21 |
| 53746051101SPIRONOLACTONE 25 MG TABLET | $0.0426 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.